Back to News
Market Impact: 0.15
SS Innovations Responds To FDA Request For Additional Information On SSi Mantra Robotic System
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationTechnology & Innovation
SS Innovations International (SSII) submitted its response on October 5, 2026, to the U.S. FDA’s request for additional information regarding its 510(k) submission for the SSi Mantra surgical robotic system. The announcement reports a regulatory-process update but does not state an FDA decision or clearance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
SSII0.10
More News
- US fines Bank of America $1.2bn for money laundering, sanctions violations
- South Korean carmaker Hyundai plans 'strategic' investment of $15.5 billion in India by 2032
- Applied Materials’ $5 billion AI lab aims to cut chip development time in half—and restore Silicon Valley’s edge
- Bank of America hit with more than $1.2 billion in penalties over money-laundering violations
- Meta’s Muse models reach the AI frontier—and kill any hopes to ‘pace’ it
- Mainspring, AEP Strike Deal to Bring Power Online Faster